Variant report
Variant | nsv964324 |
---|---|
Chromosome Location | chr4:153143531-153149109 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr4:153144653-153144916 | K562 | blood: | n/a | n/a |
2 | JUND | chr4:153146924-153147030 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | KAP1 | chr4:153144759-153144975 | HEK293 | kidney: | n/a | n/a |
4 | MAFF | chr4:153146072-153146336 | HepG2 | liver: | n/a | n/a |
5 | MAFF | chr4:153146143-153146315 | K562 | blood: | n/a | n/a |
6 | MAFK | chr4:153146152-153146287 | IMR90 | lung: | n/a | chr4:153146189-153146209 |
7 | MAFK | chr4:153146052-153146355 | HepG2 | liver: | n/a | chr4:153146189-153146209 |
8 | MAFK | chr4:153146151-153146257 | K562 | blood: | n/a | chr4:153146189-153146209 |
9 | MAFK | chr4:153146043-153146370 | HepG2 | liver: | n/a | chr4:153146189-153146209 |
10 | MYC | chr4:153144778-153144821 | K562 | blood: | n/a | n/a |
11 | POLR2A | chr4:153147654-153147765 | GM12878 | blood: | n/a | n/a |
12 | RCOR1 | chr4:153144702-153144718 | K562 | blood: | n/a | n/a |
13 | RCOR1 | chr4:153144576-153144929 | K562 | blood: | n/a | n/a |
14 | SETDB1 | chr4:153144749-153145126 | U2OS | brain: | n/a | n/a |
15 | STAT3 | chr4:153148638-153148728 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | STAT3 | chr4:153145722-153145862 | MCF10A-Er-Src | breast: | n/a | chr4:153145829-153145837 |
17 | TAL1 | chr4:153144709-153144928 | K562 | blood: | n/a | n/a |
18 | TBL1XR1 | chr4:153144639-153144836 | K562 | blood: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:153141586..153143528-chr4:153147144..153148904,2 | K562 | blood: | |
2 | chr4:153141211..153143744-chr4:153146248..153150036,3 | K562 | blood: | |
3 | chr4:153145376..153146915-chr4:153148881..153150798,2 | MCF-7 | breast: | |
4 | chr4:153145376..153146915-chr4:153148881..153150798,2 | MCF-7 | breast: |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FBXW7-1 | chr4:153146375-153146602 | NONHSAT098793 |
2 | lnc-FBXW7-1 | chr4:153146983-153147104 | NONHSAT098793 |
3 | lnc-FBXW7-1 | chr4:153146396-153146551 | XLOC_004127 |
4 | lnc-FBXW7-1 | chr4:153143620-153143911 | XLOC_004127 |
5 | lnc-FBXW7-1 | chr4:153146983-153147022 | XLOC_004127 |
6 | lnc-FBXW7-1 | chr4:153146396-153146602 | XLOC_004127 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251377 | TF binding region |
ENSG00000266244 | TF binding region |
ENSG00000266244 | chromatin interactions |
ENSG00000251377 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531818037 | chr4:153143536-153143537 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs549972888 | chr4:153143543-153143544 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs142747463 | chr4:153143552-153143553 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs535414457 | chr4:153143600-153143601 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs553761654 | chr4:153143601-153143602 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs566025051 | chr4:153143615-153143616 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs150617867 | chr4:153143627-153143628 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs140073291 | chr4:153143637-153143638 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs114894452 | chr4:153143672-153143673 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs546788171 | chr4:153143753-153143754 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs181552746 | chr4:153143777-153143778 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs555937115 | chr4:153143787-153143788 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs574593995 | chr4:153143790-153143791 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs557424095 | chr4:153143808-153143809 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs146840954 | chr4:153143825-153143826 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs560237641 | chr4:153143828-153143829 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs527560642 | chr4:153143834-153143835 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs545813092 | chr4:153143837-153143838 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs3749541 | chr4:153143877-153143878 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs140684336 | chr4:153143894-153143895 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs549952847 | chr4:153143921-153143922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150040626 | chr4:153144010-153144011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529388538 | chr4:153144066-153144067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547387182 | chr4:153144084-153144085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186212664 | chr4:153144097-153144098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539833289 | chr4:153144103-153144104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377326358 | chr4:153144124-153144125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190730800 | chr4:153144167-153144168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570329297 | chr4:153144182-153144183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532652244 | chr4:153144240-153144241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182837429 | chr4:153144254-153144255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145380552 | chr4:153144265-153144266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551227205 | chr4:153144266-153144267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574581260 | chr4:153144358-153144359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35402653 | chr4:153144363-153144364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186557140 | chr4:153144368-153144369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114428930 | chr4:153144375-153144376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377744390 | chr4:153144382-153144383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190761835 | chr4:153144389-153144390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149220223 | chr4:153144406-153144407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576298000 | chr4:153144439-153144440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554652864 | chr4:153144461-153144462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369473091 | chr4:153144463-153144464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143439738 | chr4:153144522-153144523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561599155 | chr4:153144540-153144541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529328152 | chr4:153144547-153144548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547449903 | chr4:153144582-153144583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114736244 | chr4:153144598-153144599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533127241 | chr4:153144633-153144634 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs551760210 | chr4:153144661-153144662 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 17588203 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:153141600-153143600 | Enhancers | Primary T cells fromperipheralblood | blood |
2 | chr4:153141600-153143600 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
3 | chr4:153142000-153143600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
4 | chr4:153142000-153145400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:153142600-153143600 | Enhancers | Primary T cells from cord blood | blood |
6 | chr4:153142800-153143600 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
7 | chr4:153143000-153143600 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
8 | chr4:153143000-153143600 | Enhancers | Dnd41 | blood |
9 | chr4:153143800-153144000 | Enhancers | Stomach Mucosa | stomach |
10 | chr4:153144200-153145200 | Weak transcription | Stomach Mucosa | stomach |
11 | chr4:153144800-153146400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr4:153145200-153146000 | Enhancers | Stomach Mucosa | stomach |
13 | chr4:153145200-153146200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr4:153145200-153146600 | Enhancers | Fetal Intestine Large | intestine |
15 | chr4:153145200-153146600 | Enhancers | Fetal Intestine Small | intestine |
16 | chr4:153145400-153146600 | Enhancers | Fetal Thymus | thymus |
17 | chr4:153145600-153145800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr4:153145600-153146400 | Enhancers | Fetal Kidney | kidney |
19 | chr4:153145800-153147600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr4:153146400-153147000 | Enhancers | H9 Cell Line | embryonic stem cell |
21 | chr4:153146600-153150000 | Weak transcription | Fetal Thymus | thymus |
22 | chr4:153147000-153150400 | Weak transcription | H9 Cell Line | embryonic stem cell |